ACUTE LYMPHOCYTIC LEUKEMIA COMPRHENSIVE DIAGNOSIS

Acute Lymphocytic Leukemia (ALL) / Acute Lymphoblastic Leukemia is a cancer in WBC especially lymphocyte lineage. It is the clonal expansion of lympho blasts (undifferentiated lymphoid precursors) in the peripheral blood, bone marrow, and/or other tissues, which results in impaired haematopoiesis and bone marrow failure. Most common in children and treatment results in a good chance of cure and recovery.

SYMTOMS:

Laboratory evaluation for ALL for individuals who present with signs of bone marrow infiltration (anemia, thrombocytopenia), constitutional symptoms (fever, bleeding from gums, nose bleeding, lumps in and around arm pits, neck, abdomen, pale skin, shortness of breath), leukocytosis with circulating peripheral blasts, and ALL-related complications (tumour lysis syndrome, disseminated intravascular coagulation [DIC], leukostasis)

The laboratory evaluation for AML includes blood chemistry, coagulation studies, and a CBC with a differential of white blood cells (WBCs). In addition to morphologic evaluation of the bone marrow, immunophenotypic, cytogenetic, and molecular genetic studies are necessary for accurate classification, for risk assessment, therapy strategies and prognosis.

ACUTE MYELOID LEUKEMIA COMPRHENSIVE DIAGNOSIS

Acute Myeloid Leukemia (AML) is a cancer in WBC especially myeloid lineage. It is the clonal expansion of myeloid blasts (undifferentiated myeloid precursors) in the peripheral blood, bone marrow, and/or other tissues, which results in impaired haematopoiesis and bone marrow failure. Most common in adults.

SYMTOMS:

Laboratory evaluation for AML for individuals who present with signs of bone marrow infiltration (anemia, thrombocytopenia), constitutional symptoms (fever, fatigue, anorexia, weight loss), leukocytosis with circulating peripheral blasts, and AML-related complications (tumor lysis syndrome, disseminated intravascular coagulation [DIC], leukostasis)

The laboratory evaluation for AML includes blood chemistry, coagulation studies, and a CBC with a differential of white blood cells (WBCs). In addition to morphologic evaluation of the bone marrow, immunophenotypic, cytogenetic, and molecular genetic studies are necessary for accurate classification, for risk assessment, therapy strategies and prognosis.